We are excited to announce that Hangzhou Viablife Biotech Co., Ltd. has officially received the U.S. Food and Drug Administration's (FDA) No Objection status for its biosynthesized Hydroxytyrosol under the Generally Recognized as Safe (GRAS) notification process! This significant milestone marks a new chapter in the sustainable production of bioactive ingredients.
Hydroxytyrosol, a powerful antioxidant naturally found in olives, offers numerous health benefits, especially in cardiovascular and neuroprotective support. Viablife’s patented biosynthesis technology ensures a sustainable, scalable, and environmentally friendly production process, providing a high-purity alternative to traditional extraction methods. This achievement reinforces our commitment to delivering innovative, science-driven ingredient solutions that meet the needs of global food and beverage markets.
As we continue to innovate in the production of bioactive compounds, we look forward to expanding our market presence in the U.S., supporting CPG brands and product manufacturers with a reliable, high-quality, and sustainable source of Hydroxytyrosol.
For more information about Viablife's innovations and ingredient solutions, visit: www.viablife.net
www.viablife.net
Viablife
About Author
More Stories
A Comprehensive Study of 3-tert-butyl-6-chloro-[1,2,4]triazolo[4,3-b]pyridazine CAS 263401-62-3 in Heterocyclic Chemistry
Pet Travel Accessories for Safer and More Comfortable Pet Transportation
Brazilian Keratin Treatment Products: A Simple Approach to Smoother, More Manageable Hair